Navigation Links
Factors influencing delay in breast cancer treatment differ for African-American and white women
Date:7/10/2013

CHAPEL HILL, N.C. Different factors influence delay between diagnosis and first course of treatment for breast cancer for African-American and White women.

The study used data from the Carolina Breast Cancer Study (CBCS) Phase III, a program of UNC Lineberger Comprehensive Cancer Center. Scientists found that among White women, household size and losing a job due to one's diagnosis were reasons for delay in treatment, while among African-American women, the type of treatment received influenced delay. Both African-American and White women experienced delay if they underwent immediate breast reconstruction following mastectomy. African-American women were more likely than White women to experience delay associated with this procedure (92.5 percent versus 60.6 percent).

The study was published in the July 3, 2013 issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

The researchers categorized women into two groups: those who received treatment within 30 days of diagnosis, and those whose treatment was delayed by more than 30 days.

"Our goal was to identify the factors that contribute to treatment delay and to assess whether disparities in delay exist between African-American and White women," said Sasha McGee, PhD, an epidemiology graduate student at the University of North Carolina Gillings School of Global Public Health at the time of this study.

The study found that African-American women between the ages of 20 and 49 were more than three times as likely as White women in this age range to experience treatment delay.

"The study results suggest that specific populations of women need to be targeted when characterizing and addressing determinants of treatment delay, and that younger African-American women may benefit from interventions to reduce disparities in treatment delay," said McGee.

The study population consisted of 601 women with breast cancer between the ages of 20 and 74, who were enrolled in the CBCS between 2008 and 2010. The CBCS is an ongoing population-based study that recruits women from 44 counties in in North Carolina. "We used information from interviews and questionnaires to collect socioeconomic data for each woman," McGee added. "Larger studies often use area-level information for groups of people [e.g. based on census data] and apply these data to individuals in the study, which may not always be accurate." Clinical and treatment information were obtained by reviewing the medical records for each study participant.

"One of the goals of the CBCS Phase III is to assess five- and ten-year survival for study participants once recruitment ends in 2014. Follow-up interviews for study participants will continue for up to five years after diagnosis, therefore not only will we be able to evaluate the impact of a treatment delay of more than 30 days on survival, but also the impact of barriers to treatment and healthcare access," said McGee.


'/>"/>

Contact: Dianne Shaw
dgs@med.unc.edu
919-966-7834
University of North Carolina Health Care
Source:Eurekalert

Related medicine news :

1. Program and registration open for International Annual Meeting of Human Factors/Ergonomics Professionals
2. Patient factors play key role in emergency department imaging
3. Risk factors affect the incidence of childhood pneumonia in modern urban apartment?
4. Risk Factors of Skin Cancer & Reducing That Risk
5. icandrive.ca Provides Tips to Understand the Top Factors That Affect Car Insurance Premiums
6. RKNet Studios Announced Cognitions Bridge Games for Senior Adults; to Fight Loneliness and Cognitive Decline, the Known Risk Factors in Early Death
7. Suicide risk factors mapped
8. hyperCision Inc. Announces Its Learning Migration Rapid-Deployment Solution for Helping Customers Migrate from SAP® Enterprise Learning to SuccessFactors Learning
9. Twenty-Eight Percent of Adult Americans Have Risk Factors for Pre-Diabetes But Five Out of Six Don’t Know It
10. A Number of Factors Contribute to Rise in Drug Addiction for Middle-Aged Women, According to KLEAN Treatment Center
11. Dr. Kanani, Woodland Hills Dentist, Offers Tips on Managing Risk Factors for Tooth Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... research and conference coverage on veterinary medicine, announces the launch of Veterinarian’s Money ... be packaged with the April edition of American Veterinarian™. , “We ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , ... pursue the recent RNA methylation “gold rush” with their established portfolio of optimized ... characteristics of N6-methyladenosine, or m6A , RNA methylation has received a new ...
(Date:3/27/2017)... Los Angeles, CA (PRWEB) , ... March 27, 2017 , ... ... for men with prostate cancer, including all stages, is more than 95%. Once the ... drops drastically to less than 30%. To find out how to avoid this latter ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... entered a settlement agreement to resolve the pending litigation between itself and 1800 ... the District of Utah). , “I am thrilled to announce that we have ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... Harris Communications, ... of hearing, is bringing its latest products to the Deaf Seniors of America Conference, ... have the opportunity to meet with knowledgeable ASL friendly staff from Harris Communications and ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 Summary This ... Bayer and its partnering interests and activities since 2010. ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ... The report will be delivered in PDF format within ...
(Date:3/27/2017)... LONDON , March 27, 2017 ... require to better understand Eli Lilly and its partnering interests ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ... deal and company data. The report will be ...
(Date:3/27/2017)... , March 27, 2017 ... clinical-stage pharmaceutical company specializing in the development of cannabinoid-based ... offering in the United States ... ADS representing 40 ordinary shares of the Company, ... addition, Therapix has granted the underwriters a 45-day ...
Breaking Medicine Technology: